Oliver Sartor Discusses Common Questions About Radium-223

April 1, 2016
Oliver Sartor, MD

Oliver Sartor, MD, Medical Director Tulane Cancer Center, discusses some of the most common questions patients have when starting treatment with Radium-223, and how nurses can play a role in patient education.

Oliver Sartor, MD, Medical Director Tulane Cancer Center, discusses some of the most common questions patients have when starting treatment with Radium-223, and how nurses can play a role in patient education.

Sartor says that it is vital for nurses to not only be aware of any potential side effects of Radium-223, but also to educate patients on the drug. Some common questions nurses address include how the radium will be excreted and what restrictions patients will have when interacting with other people.